P
Phylos Bioscience
Food · Portland, United States · Founded 2014
Cannabis genetics company that empowers growers of all sizes to produce high quality cannabis in a cost-effective way MoreLess
Phylos Bioscience operates at the intersection of agricultural science and data technology, focusing specifically on the cannabis and hemp industries. Founded in 2014 by Nishan Karassik and Mowgli Holmes, the company initially aimed to create a comprehensive genetic map of the cannabis plant, similar to a 23andMe for cannabis. Nishan Karassik's background in technology and sustainable agriculture, combined with Mowgli Holmes's expertise as a molecular biologist, provided the foundational knowledge for this endeavor. Holmes, who holds a PhD from Columbia University, was driven by the potential to apply modern genomic science to a plant with a long, yet poorly documented, history of cultivation.
The company's core business revolves around providing genomic testing and data services to cultivators, breeders, and researchers within the cannabis market. Its primary offering is a suite of genetic tests that can identify a plant's lineage, cannabinoid and terpene profiles, and sex. This information empowers growers to make more informed decisions, optimize their cultivation practices for desired traits, and protect their intellectual property. The business model is primarily service-based, generating revenue from the sale of these testing kits and the associated data analysis. Phylos serves a diverse clientele, ranging from large-scale commercial growers to smaller craft producers and research institutions.
A significant development in the company's trajectory was the introduction of its own proprietary cannabis seeds. This move represented a strategic pivot from being purely a data and testing provider to also becoming a direct supplier of plant genetics. This vertical integration allows Phylos to leverage its vast genetic database to breed new varieties with specific, commercially desirable characteristics, such as high yields or specific chemical profiles. This expansion into seed production provides a new and substantial revenue stream, positioning the company as a key player in the supply chain for cannabis cultivation. The company's database, known as The Phylos Galaxy, has been a central part of its identity, mapping the genetic relationships between thousands of cannabis strains and making this information accessible to its clients.
Keywords: cannabis genetics, hemp genomics, agricultural biotechnology, plant breeding, genetic testing, seed production, cultivation data, molecular biology, crop science, agritech
Company overview
Phylos Bioscience company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Portland, United States
- Employees
- 49
- Open positions
- None listed
- Dealroom signal
- 72.6
Valuation & funding
Phylos Bioscience funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLE✓Equity / VC | Jul 2024 | $1M | — | OrganiGram | ↗ |
| CONVERTIBLE✓Equity / VC | Nov 2023 | $2.8M | — | OrganiGram | ↗ |
| CONVERTIBLE✓Equity / VC | May 2023 | $3.3M | — | OrganiGram | ↗ |
| LATE VC✓Equity / VC | Feb 2023 | $4.5M | $38M | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Feb 2022 | $7.6M | $30M | Accomplice · Merida Capital Partners · Entourage Effect Capital | ↗ |
| OtherOther financing | Apr 2019 | Undisclosed | — | ||
| SERIES C✓Equity / VC | Apr 2017 | Slow Ventures | — | ||
| SEED✓Equity / VC | Feb 2015 | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 49 |
| 2025 | 48 |
| 2024 | 49 |
| 2023 | 44 |
| 2022 | 30 |
| 2021 | 31 |
| 2020 | 36 |
Growth signals
Phylos Bioscience website traffic
Latest recorded traffic for Phylos Bioscience is 17K monthly website visits, up 153.7% over the last three months. Phylos Bioscience's team grew 2.1% over the past year.
Comparisons
Phylos Bioscience compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Phylos Bioscience's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Phylos Bioscience has talent and traffic
team presence
In the news
Latest news about Phylos Bioscience
Recent press, funding announcements, and product moves mentioning Phylos Bioscience — open to read from the original sources.
Market sentiment
What the market is saying about Phylos Bioscience
An AI-synthesized read of the highest-engagement posts about Phylos Bioscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phylos Bioscience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.












